Skip to main content

stock

LGNZZ · LIGAND PHARMACEUTICALS INC

What LIGAND PHARMACEUTICALS INC reports to the SEC, read from its filings.

Open in the app

Price

The live LGNZZ price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on LGNZZ.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
19,935,609 as of 2026-08-04 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
32.6%
Net
67.9%

Returns

ROE
20.4%
ROA
9.0%

Health

Current ratio
31.2x
Debt/equity
1.2x

Deep value

NCAV
$238.76M
NCAV per share
$11.98
Price/NCAV
Locked
NNWC
-$156.27M
NNWC per share
-$7.84
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$63.69M—Gross profit: unreported by this company.$8.59M$48.51M
10-Q filed 2026-08-07
2026-03-31$51.72M—Gross profit: unreported by this company.$17.37M-$13.35M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$59.67M—Gross profit: unreported by this company.$13.84M$44.78M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$115.46M—Gross profit: unreported by this company.$54.93M$117.27M
10-Q filed 2025-11-07
2025-06-30$47.63M—Gross profit: unreported by this company.$8.44M$4.85M
10-Q filed 2026-08-07
2025-03-31$45.33M—Gross profit: unreported by this company.-$36.22M-$42.45M
10-Q filed 2026-05-08
2024-12-31$42.81M—Gross profit: unreported by this company.-$9.64M-$31.09M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$51.81M—Gross profit: unreported by this company.$3.14M-$7.17M
10-Q filed 2025-11-07
Assets
$2.19B
Equity
$967.52M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$268.09M$41.00M$124.45M$48.91M
2024-12-31$167.13M-$22.61M-$4.03M$95.23M
2023-12-31$131.31M$11.94M$52.15M$46.06M
2022-12-31$196.25M$3.04M-$33.36M$119.93M
2021-12-31$241.54M$103.85M$57.14M$70.04M
2020-12-31$163.56M$37.50M-$2.98M$50.13M
2019-12-31$120.28M$807.08M$629.30M-$31.89M
2018-12-31$251.45M$163.73M$143.32M$193.17M
2017-12-31$141.10M$68.08M$12.56M$86.41M
2016-12-31$108.97M$43.88M-$1.64M$58.88M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

News

Stories that named LGNZZ, and the market events around them.

Sign in to see this

Board

The LGNZZ board could not be loaded.

Retry the LGNZZ board

nakagai

Signals on LGNZZ come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the LGNZZ board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

LIGAND PHARMACEUTICALS INC (LGNZZ): SEC filings, financials and insider trades · Nakagai